PLGA Nanoparticles for Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: A Novel Approach towards Reduction of Renal Radiation Dose

BACKGROUND: Peptide receptor radionuclide therapy (PRRT), employed for treatment of neuroendocrine tumors (NETs) is based on over-expression of Somatostatin Receptors (SSTRs) on NETs. It is, however, limited by high uptake and retention of radiolabeled peptide in kidneys resulting in unnecessary rad...

Descripción completa

Detalles Bibliográficos
Autores principales: Arora, Geetanjali, Shukla, Jaya, Ghosh, Sourabh, Maulik, Subir Kumar, Malhotra, Arun, Bandopadhyaya, Gurupad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307778/
https://www.ncbi.nlm.nih.gov/pubmed/22442740
http://dx.doi.org/10.1371/journal.pone.0034019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307778/
https://www.ncbi.nlm.nih.gov/pubmed/22442740
http://dx.doi.org/10.1371/journal.pone.0034019

Ejemplares similares